Abstracts from our breaking clinical trials
At ESMO this year, we will share new data from our robust portfolio and pipeline of advanced therapeutic platforms in solid tumors, showcasing the impact of our bold science in cancer research.
Novartis continues to pursue scientific breakthroughs with the ambition to transform lives and renew patients’ hopes for the future. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines.
This site may contain information of products which have not been authorized in your country.
Please note that the following content is exclusively addressed to healthcare professionals and its correct interpretation requires specialized training.
Are you a healthcare professional?